Atlas Trials

Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease

Clinical trial NCT02484755 · UNKNOWN

Trial details

NCT number
NCT02484755
Sponsor
Huashan Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Cushing's DiseaseCorticotrophin Adenoma
Start date
2015-06-01
Primary completion
2015-09-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.